Acrivon Therapeutics
(NASDAQ:ACRV)
$8.56
-0.09[-1.04%]
At close: May 16
$8.56
0[0.00%]
After Hours: 4:00PM EDT
Q1 2024 Earnings were released on Tue May 14th, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Acrivon Therapeutics Stock (NASDAQ:ACRV), Quotes and News Summary

Acrivon Therapeutics Stock (NASDAQ: ACRV) stock price, news, charts, stock research, profile.

Open$8.530
Close$8.560
Volume / Avg.41.682K / 778.372K
Day Range8.450 - 8.810
52 Wk Range3.190 - 14.300
Market Cap$264.294M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
50
Short Interest
9.27%
Days to Cover3.2

Recent News

Crude Oil Down Over 1%; Cognyte Software Shares Plummet
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0.46% to 38,713.72 while the NASDAQ fell 0.24% to 16,215.32. The S&P 500 also fell, dropping, 0.39% to 5,182.36.
Avi Kapoor
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free
Avi Kapoor
Dow Dips 150 Points; Laser Photonics Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,742.12 while the NASDAQ fell 0.16% to 16,227.77. The S&P 500 also fell, dropping, 0.29% to 5,187.10.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Mar
5
1
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ACRV
MGNX

FAQ

Q

How do I buy Acrivon Therapeutics (ACRV) stock?

A

You can purchase shares of Acrivon Therapeutics (NASDAQ: ACRV) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acrivon Therapeutics's (ACRV) competitors?

A

Other companies in Acrivon Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Inozyme Pharma (NASDAQ:INZY), Opthea (NASDAQ:OPT), Monte Rosa Therapeutics (NASDAQ:GLUE) and Century Therapeutics (NASDAQ:IPSC).

Q

What is the target price for Acrivon Therapeutics (ACRV) stock?

A

The latest price target for Acrivon Therapeutics (NASDAQ: ACRV) was reported by BMO Capital on Wednesday, May 15, 2024. The analyst firm set a price target for 25.00 expecting ACRV to rise to within 12 months (a possible 192.06% upside). 18 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Acrivon Therapeutics (ACRV)?

A

The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $8.56 last updated Today at May 16, 2024 at 4:00 PM EDT.

Q

Does Acrivon Therapeutics (ACRV) pay a dividend?

A

There are no upcoming dividends for Acrivon Therapeutics.

Q

When is Acrivon Therapeutics (NASDAQ:ACRV) reporting earnings?

A

Acrivon Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.

Q

Is Acrivon Therapeutics (ACRV) going to split?

A

There is no upcoming split for Acrivon Therapeutics.

Q

What sector and industry does Acrivon Therapeutics (ACRV) operate in?

A

Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch